Landos Biopharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.70
|
|
Average Rating
|
2.33
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.28
|
-0.20
|
0.08
|
28.57%
|
|
2022-06-30
|
-0.36
|
-0.28
|
0.08
|
22.22%
|
|
2022-03-31
|
-0.35
|
-0.37
|
-0.02
|
-5.71%
|
|
2021-12-31
|
-0.33
|
-0.40
|
-0.07
|
-21.21%
|
|
2021-09-30
|
-0.44
|
-0.32
|
0.12
|
27.27%
|
|
2021-06-30
|
-0.14
|
0.12
|
0.26
|
185.71%
|
|
2021-03-31
|
-0.37
|
-0.38
|
-0.01
|
-2.70%
|
|
2020-12-31
|
-0.69
|
-0.91
|
-0.22
|
-31.88%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.85
|
|
2021-12-31
|
-0.98
|
|
2020-12-31
|
-1.71
|
|
2019-12-31
|
-1.02
|
|
2018-12-31
|
-0.31
|